FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to medicine, namely to immunology and molecular biology, and concerns a method for determining the expression level of a gene coding ZO-1 in rabbit eye tissues (Oryctolagus cuniculus), using real-time RT-PCR and a kit for detecting said gene.
EFFECT: disclosed is a method for determining the level of expression of a gene coding ZO-1 in rabbit eye tissues and a kit for determining said method.
2 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING GENE EXPRESSION LEVEL, CODING PEDF, IN ORYCTOLAGUS CUNICULUS RABBIT EYE TISSUES AND A KIT FOR ITS DETERMINING | 2021 |
|
RU2765437C1 |
| METHOD FOR DETERMINING LEVEL OF EXPRESSION OF GENE ENCODING CCL-2 IN TISSUES OF EYE OF RABBIT ORYCTOLAGUS CUNICULUS, AND KIT FOR ITS DETERMINATION | 2020 |
|
RU2750940C1 |
| METHOD FOR DETERMINING THE LEVEL OF EXPRESSION OF THE GENE ENCODING IL-18 IN THE TISSUES OF THE EYE OF THE ORYCTOLAGUS CUNICULUS RABBIT, AND DETERMINATION KIT | 2020 |
|
RU2745323C1 |
| METHOD FOR DETERMINING THE EXPRESSION LEVEL OF THE GENE ENCODING VEGF-A IN THE EYE TISSUES OF THE ORYCTOLAGUS CUNICULUS RABBIT, AND A KIT FOR ITS DETERMINATION | 2021 |
|
RU2761339C1 |
| METHOD FOR DETERMINING EXPRESSION LEVEL OF GENE CODING 1L-1β IN RABBIT EYE TISSUES (ORYCTOLAGUS CUNICULUS), AND KIT FOR IMPLEMENTATION THEREOF | 2019 |
|
RU2731062C1 |
| QUANTITATIVE METHOD FOR DETERMINING THE EXPRESSION OF GNAO1 ALLELES OF A HEALTHY FORM AND WITH c.607 G>A MUTATION | 2021 |
|
RU2777663C1 |
| QUANTIFICATION OF THE hsa-miR-30c-5/VIM, hsa-miR-28-3p/VIM, hsa-miR-1-3p/ANXA2, hsa-miR-30c-5p/FBN1, hsa-miR-15b-5p/MYL6 tr.v.1, hsa-miR-15b-5p/MYL6 tr.v.2, hsa-miR-185-3p/FLNA, hsa-miR-1-3p/YWHAZ, hsa-miR-30c-5p/YWHAZ AND hsa-miR-654-3p/FGA RATIO IN THE PLACENTAL SITE OF WOMEN ON THE DAY OF DELIVERY AT A TERM OF MORE THAN 34 WEEKS OF GESTATION AS A METHOD FOR DIFFERENTIAL DIAGNOSIS OF FETAL GROWTH RESTRICTION SYNDROME, PREECLAMPSIA AND A SMALL FOR GESTATIONAL AGE FETUS SYNDROME | 2021 |
|
RU2771205C1 |
| METHODS FOR DETERMINING PATIENT'S SUSCEPTIBILITY TO NOSOCOMIAL INFECTION AND PREDICTING DEVELOPMENT OF A SEPTIC SYNDROME | 2014 |
|
RU2663724C2 |
| METHODS FOR PATIENT'S RESPONSE TO HOSPITAL INFECTION TEST AND FORECASTING OF DEVELOPING SEPSIS SYNDROME | 2010 |
|
RU2525707C2 |
| METHOD OF DETERMINING LEVEL OF CHIMERIC GENE Trim5a EXPRESSION | 2015 |
|
RU2592675C1 |
